Literature DB >> 341941

Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo.

H Kopera.   

Abstract

1. Eighteen healthy male volunteers were treated at random in double-blind conditions with mianserin, amitriptyline, or placebo for 8 days. Measurements were made of various parameters indicative of anticholinergic and blood pressure effects. 2. Mianserin showed no significant anticholinergic effects on any of the measures used. Compared with placebo, mianserin significantly reduced pupil diameter and tended to increase salivary production and increase the distance of the near point. 3. Amitriptyline showed evidence of anticholinergic effects in that salivary production fell to a level significantly lower than that of the mianserin- or placebo-treated subjects. The distance of the near point tended to increase during amitriptyline treatment. Compared with placebo, amitriptyline also significantly reduced pupil diameter on some occasions. 4. Amitriptyline produced postural hypotension to a statistically significant degree, whereas this effect was not observed during mianserin treatment. 5. In conclusion, mianserin in doses of up to 60 mg daily given to healthy males seemed to lack the anticholinergic effects and postural hypotension associated with amitriptyline treatment.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 341941      PMCID: PMC1429208     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Clinical pharmacology and pharmacokinetics of clonidine.

Authors:  C T Dollery; D S Davies; G H Draffan; H J Dargie; C R Dean; J L Reid; R A Clare; S Murray
Journal:  Clin Pharmacol Ther       Date:  1976-01       Impact factor: 6.875

2.  Cardiovascular complications of imipramine intoxication.

Authors:  M H Sacks; R J Bonforte; R P Laser; I Dimich
Journal:  JAMA       Date:  1968-08-19       Impact factor: 56.272

3.  [Cardiotoxicity of tricyclic antidepressive agents. (Phenothiazines and imipramines)].

Authors:  T Moccetti; P Lichtlen; H Albert; E Meier; P Imbach
Journal:  Schweiz Med Wochenschr       Date:  1971-01-09

4.  Mianserin versus amitriptyline. A double-blind-trial evaluated by the AMP system.

Authors:  H P Vogel; D Bente; J Feder; H Helmchen; B Müller-Oerlinghausen; N Bohacek; M Mihovilović; A Brändli; J Fleischhauer; W Walcher
Journal:  Int Pharmacopsychiatry       Date:  1976

5.  Mianserin hydrochloride: a novel antidepressant.

Authors:  A Coppen; R Gupta; S Montgomery; K Ghose; J Bailey; B Burns; J J de Ridder
Journal:  Br J Psychiatry       Date:  1976-10       Impact factor: 9.319

6.  Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness.

Authors:  K Ghose; A Coppen; P Turner
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

  6 in total
  21 in total

1.  Variability in the elimination of mianserin in elderly patients.

Authors:  E J Begg; J R Sharman; J E Kidd; R Sainsbury; D W Clark
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

2.  Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy.

Authors:  H Palomäki; M Kaste; A Berg; R Lönnqvist; J Lönnqvist; M Lehtihalmes; J Hares
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

3.  Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin.

Authors:  E J Sabine; A Yonace; A J Farrington; K H Barratt; A Wakeling
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

4.  Assessment of the anticholinergic effects of antidepressants in a single-dose cross-over study of salivation and plasma levels.

Authors:  L Clemmesen; P L Mikkelsen; H Lund; T G Bolwig; O J Rafaelsen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 5.  Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

6.  Absence of an effect of mianserin on the actions of clonidine or methyldopa in hypertensive patients.

Authors:  H L Elliott; K McLean; D J Sumner; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Assessment of the interaction between mianserin and centrally-acting antihypertensive drugs.

Authors:  H L Elliott; B Whiting; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

8.  Comparison of the antimuscarinic activity of mianserin and amitriptyline in the cat superior cervical ganglion.

Authors:  Y H Kwok; F Mitchelson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

9.  The effect of some antidepressants on prejunctional muscarinic receptors on the sympathetic nerves of the isolated rabbit ear artery.

Authors:  Y H Kwok; F Mitchelson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000

10.  A comparison of the effects of single doses of amoxapine and amitriptyline on autonomic functions in healthy volunteers.

Authors:  M Bourne; E Szabadi; C M Bradshaw
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.